4Iwata H,Kobayashi S,Masaoka A,et al.Production of matrix metalloproteinase and tissue inhibitors in human breast carcinomas[J].Jpn J Cancer Res,1996,87:602-611.
5Talvensaari-Mattila A,Paakko P,Hoyhtya M,et al.Matrix metalloproteinase-2 immunoreactive protein:a marker of aggressive in breast carcinoma[J].Cancer,1998,83:1153-1162.
6Leeman M F,McKay J A,Murray G I,et al.Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer[J].J Clin Pathol,2002,55:758-762.
7Thomas G T,Lewis M P,Speight P M,et al.Matrix metalloproteinases and oral cancer[J].Oral Oncol,1999,35:227-233.
8Ala-Aho R,Johansson N,Baker A H,et al.Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosarcoma HT-1080 cells[J].Int J Cancer,2002,97:283-289.
9Nakopoulou L,Giannopoulou I,Gakiopoulou H,et al.Matrix metalloproteinase-1 and -3 in breast cancer:correlation with progesterone receptors and other clinicopathologic features[J].Hum Pathol,1999,30:436-442.
10Pendas A M,Uria J A,Jimenez M G,et al.An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies[J].Clin Chim Acta,2000,291:137-155.